Niva Bupa Health Insurance has received regulatory approval from the Insurance Regulatory and Development Authority of India (IRDAI) for the re-appointment of Mr. Krishnan Ramachandran as Chief Executive Officer and Managing Director. The re-appointment is effective for a five-year term from May 1, 2025, to April 30, 2030.
Board and shareholder approval already in place
The move comes after prior approval from the company’s Board of Directors on February 4, 2025, and shareholder endorsement on March 28, 2025, both subject to final clearance from the regulator. The IRDAI officially granted the approval via email on April 22, 2025, under Section 34A of the Insurance Act, 1938.
Mr. Ramachandran has been instrumental in shaping Niva Bupa’s growth in the Indian health insurance sector, and the extension of his leadership signals continuity in strategic direction.
No financial impact or penalties
The company confirmed that the re-appointment has no financial implications or compliance issues. No penalties, restrictions, or aberrations were cited in the IRDAI’s communication.
FAQs
Who has been re-appointed as CEO and MD of Niva Bupa?
Mr. Krishnan Ramachandran has been re-appointed for a five-year term.
When does the new term begin?
The term is effective from May 1, 2025, and will run until April 30, 2030.
Was regulatory approval required?
Yes, the appointment required approval from IRDAI under the Insurance Act, 1938.
Were any penalties or issues flagged by IRDAI?
No, the approval was granted without any conditions or sanctions.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
